R717 (Lamotrigine Extended-Release 25 mg)
Pill with imprint R717 is Yellow, Round and has been identified as Lamotrigine Extended-Release 25 mg. It is supplied by Dr. Reddy's Laboratories, Inc.
Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for R717

Lamotrigine Extended-Release
- Imprint
- R717
- Strength
- 25 mg
- Color
- Yellow
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy's Laboratories, Inc.
- National Drug Code (NDC)
- 55111-0717
- Inactive Ingredients
-
hypromelloses,
ferrosoferric oxide,
ferric oxide yellow,
lactose monohydrate,
magnesium stearate,
polyethylene glycol 400,
magnesium silicate,
titanium dioxide,
triethyl citrate,
shellac,
methacrylic acid - ethyl acrylate copolymer (1:1) type a
Note: Inactive ingredients may vary.
Related images for "R717"
More about lamotrigine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1,545)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: triazine anticonvulsants
Patient resources
- Drug Information
- Lamotrigine Extended-Release Tablets
- Lamotrigine Tablets
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Orally Disintegrating Tablets
Other brands
Lamictal, Lamictal XR, Lamictal ODT, Subvenite, Lamictal CD
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.